Published in Int J Colorectal Dis on January 24, 2007
Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J (2010) 2.57
An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study. Br J Cancer (2011) 2.21
Is hypoalbuminemia an independent prognostic factor in patients with gastric cancer? World J Surg (2010) 1.94
The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study. Br J Cancer (2010) 1.73
Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer (2007) 1.57
Low preoperative serum albumin in colon cancer: a risk factor for poor outcome. Int J Colorectal Dis (2010) 1.40
Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer. Br J Cancer (2009) 1.35
Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer. World J Surg (2012) 1.18
The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma. BMC Cancer (2013) 1.13
Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study. Cancer Epidemiol Biomarkers Prev (2011) 1.11
The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer. Br J Cancer (2008) 1.10
The role of chronic inflammation in obesity-associated cancers. ISRN Oncol (2013) 1.04
A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma. PLoS One (2015) 1.04
C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review. PLoS One (2015) 1.03
Identification of prognostic inflammatory factors in colorectal liver metastases. BMC Cancer (2014) 1.02
The value of the pretreatment albumin/globulin ratio in predicting the long-term survival in colorectal cancer. Int J Colorectal Dis (2013) 0.98
Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed. J Clin Oncol (2015) 0.97
The modified glasgow prognostic score is an independent prognostic factor in patients with inoperable thoracic esophageal squamous cell carcinoma undergoing chemoradiotherapy. J Cancer (2014) 0.94
Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients. World J Gastroenterol (2015) 0.93
A nomogram to predict prognostic values of various inflammatory biomarkers in patients with esophageal squamous cell carcinoma. Am J Cancer Res (2015) 0.93
Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer. J Cancer Res Clin Oncol (2016) 0.93
Pre-operative hypoalbuminaemia predicts poor overall survival in rectal cancer: a retrospective cohort analysis. BMC Clin Pathol (2013) 0.93
Comparison of tumour-based (Petersen Index) and inflammation-based (Glasgow Prognostic Score) scoring systems in patients undergoing curative resection for colon cancer. Br J Cancer (2009) 0.92
Areca nut chewing and systemic inflammation: evidence of a common pathway for systemic diseases. J Inflamm (Lond) (2012) 0.92
Inflammation-based scores: a new method for patient-targeted strategies and improved perioperative outcome in cancer patients. Biomed Res Int (2014) 0.91
The Glasgow prognostic score is valuable for colorectal cancer with both synchronous and metachronous unresectable liver metastases. Oncol Lett (2012) 0.90
Prognostication of Survival in Patients With Advanced Cancer: Predicting the Unpredictable? Cancer Control (2015) 0.89
Inflammation-based score (Glasgow prognostic score) as an independent prognostic factor in colorectal cancer patients. Ann Surg Treat Res (2014) 0.89
Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma. Medicine (Baltimore) (2015) 0.88
The modified Glasgow prognostic score as a predictor of survival after hepatectomy for colorectal liver metastases. Ann Surg Oncol (2014) 0.88
Improved 5-Factor Prognostic Classification of Patients Receiving Salvage Systemic Therapy for Advanced Urothelial Carcinoma. J Urol (2015) 0.88
Esophageal stenosis and the Glasgow Prognostic Score as independent factors of poor prognosis for patients with locally advanced unresectable esophageal cancer treated with chemoradiotherapy (exploratory analysis of JCOG0303). Int J Clin Oncol (2017) 0.86
Prognostic significance of Glasgow prognostic score in patients undergoing esophagectomy for esophageal squamous cell carcinoma. Saudi J Gastroenterol (2014) 0.85
Glasgow prognostic score predicts outcome after surgical resection of gallbladder cancer. World J Surg (2015) 0.84
Prognostic role of platelet-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis. Medicine (Baltimore) (2016) 0.83
Changes of acute-phase protein levels in the serum of lung cancer patients following radiotherapy. Int J Clin Exp Med (2012) 0.83
A prospective study of the role of inflammation in bladder cancer. Curr Urol (2013) 0.83
A new inflammation index is useful for patients with esophageal squamous cell carcinoma. Onco Targets Ther (2014) 0.82
Usefulness of an inflammation-based prognostic score (mGPS) for predicting survival in patients with unresectable malignant biliary obstruction. World J Surg (2013) 0.82
Prognostic indicators based on inflammatory and nutritional factors after pancreaticoduodenectomy for pancreatic cancer. Surg Today (2016) 0.81
An inflammatory biomarker-based nomogram to predict prognosis of patients with nasopharyngeal carcinoma: an analysis of a prospective study. Cancer Med (2016) 0.81
Adjuvant chemotherapy for resected colon cancer: comparison of the prognostic value of tumour and patient related factors. Int J Colorectal Dis (2011) 0.81
Skeletal muscle mass is associated with severe dysphagia in cancer patients. J Cachexia Sarcopenia Muscle (2015) 0.81
Relationship Between 18F-Fluorodeoxyglucose Uptake and V-Ki-Ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Mutation in Colorectal Cancer Patients: Variability Depending on C-Reactive Protein Level. Medicine (Baltimore) (2016) 0.81
Hypoalbuminemia in colorectal cancer prognosis: Nutritional marker or inflammatory surrogate? World J Gastrointest Surg (2015) 0.80
The modified Glasgow Prognostic Score (mGPS) is a good predictor of indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancers. Int J Clin Oncol (2013) 0.80
Prognostic factors for recurrence-free and overall survival after adrenalectomy for metastatic carcinoma: a retrospective cohort pilot study. BMC Urol (2014) 0.80
Prognostic significance of Glasgow prognostic score in patients with stage II colorectal cancer. Int J Clin Exp Med (2015) 0.79
Systemic inflammatory response associated with distant metastasis of T1 or T2 colorectal cancer. Dig Dis Sci (2010) 0.78
From genotype to functional phenotype: unraveling the metabolomic features of colorectal cancer. Genes (Basel) (2014) 0.78
Correlation between preoperative systemic inflammation and postoperative infection in patients with gastrointestinal cancer: a multicenter study. Surg Today (2013) 0.78
Simple and Objective Prediction of Survival in Patients with Lung Cancer: Staging the Host Systemic Inflammatory Response. Lung Cancer Int (2014) 0.78
Preoperative Serum Interleukin-6 Is a Potential Prognostic Factor for Colorectal Cancer, including Stage II Patients. Gastroenterol Res Pract (2015) 0.78
A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma. Int J Mol Sci (2016) 0.77
Activated systemic inflammatory response at diagnosis reduces lymph node count in colonic carcinoma. World J Gastrointest Oncol (2016) 0.77
A novel inflammation-based prognostic score for patients with esophageal squamous cell carcinoma: the c-reactive protein/prognostic nutritional index ratio. Oncotarget (2016) 0.77
Association between pretreatment Glasgow prognostic score and gastric cancer survival and clinicopathological features: a meta-analysis. Onco Targets Ther (2016) 0.77
The C-reactive protein/albumin ratio predicts long-term outcomes of patients with operable non-small cell lung cancer. Oncotarget (2016) 0.77
Malnutrition, inflammation: which parameter is interesting to detect in planned oncologic surgery? World J Surg (2009) 0.77
Preoperative selection of patients with colorectal cancer liver metastasis for hepatic resection. World J Gastroenterol (2016) 0.76
Long-term outcomes and prognostic factors of patients with obstructive colorectal cancer: A multicenter retrospective cohort study. World J Gastroenterol (2016) 0.75
Predictive value of the modified Glasgow Prognostic Score for the therapeutic effects of molecular-targeted drugs on advanced renal cell carcinoma. Mol Clin Oncol (2017) 0.75
Procalcitonin improves the Glasgow Prognostic Score for outcome prediction in emergency patients with cancer: a cohort study. Dis Markers (2015) 0.75
Modified glasgow prognostic score predicting high conversion ratio in opioid switching from oral oxycodone to transdermal fentanyl in patients with cancer pain. Int J Clin Exp Med (2015) 0.75
Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma. PLoS One (2016) 0.75
The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma. Oncotarget (2016) 0.75
The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer. Springerplus (2016) 0.75
Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer. Oncotarget (2016) 0.75
Glasgow Prognostic Score (GPS) can be a useful indicator to determine prognosis of patients with colorectal carcinoma. Int Surg (2014) 0.75
Immunization-based scores as independent prognostic predictors in soft tissue sarcoma patients. J Cancer (2017) 0.75
Decision support systems for incurable non-small cell lung cancer: a systematic review. BMC Med Inform Decis Mak (2017) 0.75
Inflammation-based prognostic scores as indicators to select candidates for primary site resection followed by multimodal therapy among colorectal cancer patients with multiple metastases. Int J Clin Oncol (2017) 0.75
Assessment of the relationship between neutrophil lymphocyte ratio and prognostic factors in non-metastatic colorectal cancer. Turk J Surg (2017) 0.75
Morphologic change of the psoas muscle as a surrogate marker of sarcopenia and predictor of complications after colorectal cancer surgery. Int J Colorectal Dis (2017) 0.75
Glasgow prognostic score predicts therapeutic outcome after hepatic resection for hepatocellular carcinoma. Oncol Lett (2017) 0.75
The spread of rectal cancer and its effect on prognosis. Br J Cancer (1958) 10.06
Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg (2003) 6.04
Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer (2003) 3.44
Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr (2006) 2.66
Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer. Br J Cancer (2006) 2.33
Cachexia. Ann Intern Med (2000) 2.29
Risk factors for morbidity and mortality after colectomy for colon cancer. Dis Colon Rectum (2000) 2.22
Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer (2001) 2.10
C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J Am Coll Cardiol (2006) 1.96
Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients. Nutr Cancer (1998) 1.88
Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg (1998) 1.88
Inflammatory markers and cardiovascular health in older adults. Cardiovasc Res (2005) 1.71
Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group. Ann Surg Oncol (2000) 1.58
Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer. Br J Cancer (2006) 1.48
A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer (2005) 1.46
Outcome following surgery for colorectal cancer: analysis by hospital after adjustment for case-mix and deprivation. Br J Cancer (2002) 1.39
Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough? Ann Oncol (2003) 1.36
Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer. Pancreatology (2006) 1.34
Serum albumin: a prognostic indicator in patients with colorectal cancer. J R Coll Surg Edinb (1998) 1.18
Pancreatic cancer as a model: inflammatory mediators, acute-phase response, and cancer cachexia. World J Surg (1999) 1.16
Outcome after proctectomy for rectal cancer in Department of Veterans Affairs Hospitals: a report from the National Surgical Quality Improvement Program. Ann Surg (1998) 1.14
Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. Lancet (2003) 3.89
Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection? Ann Surg (2006) 2.17
Epidemiology of colorectal liver metastases. Surg Oncol (2007) 1.29
ABC of obesity. Obesity and cancer. BMJ (2006) 1.22
Patterns and predictors of early recurrence in postmenopausal women with estrogen receptor-positive early breast cancer. Breast Cancer Res Treat (2008) 1.19
A prospective study of the impact of weight loss and the systemic inflammatory response on quality of life in patients with inoperable non-small cell lung cancer. Lung Cancer (2003) 1.17
Prospective multicenter trial evaluating a novel method of characterizing focal liver lesions using contrast-enhanced sonography. AJR Am J Roentgenol (2006) 1.12
Score based on hypoalbuminemia and elevated C-reactive protein predicts survival in patients with advanced gastrointestinal cancer. Nutr Cancer (2004) 1.05
A case of septicaemic anthrax in an intravenous drug user. BMC Infect Dis (2011) 0.99
[131I]meta-iodobenzylguanidine and topotecan combination treatment of tumors expressing the noradrenaline transporter. Clin Cancer Res (2005) 0.98
Surgery for colorectal cancer. Br Med Bull (2002) 0.91
The systemic inflammatory response predicts overall and cancer specific survival in patients with malignant lymphoma. Med Sci Monit (2005) 0.86
Vitamin antioxidants, lipid peroxidation, tumour stage, the systemic inflammatory response and survival in patients with colorectal cancer. Int J Cancer (2008) 0.86
Microsatellite analysis for determination of the mutagenicity of extremely low-frequency electromagnetic fields and ionising radiation in vitro. Mutat Res (2006) 0.86
Tumor size is associated with the systemic inflammatory response but not survival in patients with primary operable colorectal cancer. J Gastroenterol Hepatol (2007) 0.80
The effect of gender on postoperative mortality after emergency abdominal surgery. Gend Med (2005) 0.80
Performance status of male and female advanced cancer patients is independently predicted by mid-upper arm circumference measurement. Nutr Cancer (2002) 0.77
Natural antibiotic expression in celiac disease--correlation with villous atrophy and response to a gluten-free diet. Dig Dis Sci (2005) 0.76
Contrast-enhanced Doppler perfusion index: clinical and experimental evaluation. J Ultrasound Med (2002) 0.76
Adult intussusception presenting as rectal prolapse. BMJ Case Rep (2014) 0.75
Correlation between erosive oesophageal and gastro-duodenal diseases. the influence of aspirin, simple analgesics, and Helicobacter pylori. Eur J Gastroenterol Hepatol (2002) 0.75